Tom Denee

Market Access, Health Economics and Reimbursement project for Janssen compounds in: - Oncology - Hepatitis C - HIV - RSV - Neurosciences

Supporting the Global Commercial Strategic Organization Hepatitis Team in Market Access and Health Economics projects for simeprevir and future Hepatitis C compounds

Supporting the Health Economics, Market Access & Reimbursement team for the Dutch market in Market Access and Health Economics project to prepare for the launch of a new compound in hematology

- Since Jan 2013, co-lead of Global Product Team Dukoral (cholera vaccine), defining the global product strategy, life cycle management, and responsible for the global Net Margin - Quinvaxem (pediatric pentavalent vaccine) marketing and forecasting - In 2012, Inflexal V (flu vaccine) supply negotiations and process improvements - Building business cases for e.g.,: entering new countries, clinical trials for MT

- Create and update business case model to valuate organization for a potential acquisition - Create and update population based forecasting model for pentavalent vaccines and specifically Quinvaxem global sales - Create and manage global marketing plans for Quinvaxem - Manage business case for pipeline product and be part of development project core team

Pharmacist in public pharmacy Koert (80-110 employees) in Utrecht, 12 hours per week and 40 hours per week during holidays. Primary tasks: patient care, giving oral information, and also inserting and checking prescriptions and checking medicine-computing-signals and if necessary follow these up. Since summer 2009 also at least 4 hours per week organizing the medicine distribution of prisoners in prison region Utrecht, in Houten.

Innovation Management